期刊文献+

食管导联心电图优化左房室间期对双腔起搏器植入的三度房室阻滞患者的影响 被引量:1

暂未订购
导出
摘要 目的探讨食管导联心电图优化左房室间期(LAVI)对双腔起搏器植入的三度房室阻滞(Ⅲ°AVB)患者的影响。方法选取开封市中心医院2018年10月至2020年10月收治的100例行双腔起搏器植入治疗的Ⅲ°AVB患者,按入院顺序分为对照组和观察组,各50例,对照组给予经验性程控房室间期,观察组使用食管导联及体表导联心电图优化LAVI,对比心功能、心脏血流动力学、运动耐力。结果观察组术后6个月的左室射血分数(LVEF)(62.44±3.49)%大于对照组(57.68±3.24)%,等容舒张时间(IVRT)(115.23±6.92)ms短于对照组(118.46±7.64)ms,LAVI、脑钠肽前体(Pro-BNP)、左心室舒张末期内径(LVEDD)、二尖瓣口舒张早期血流速度(E)分别为:(30.31±3.56)、(115.63±10.54)pg/mL、(42.13±1.48)mm、(62.08±4.34)cm/s,低于对照组(34.50±3.75)、(169.35±12.67)pg/mL、(44.76±1.56)mm、(73.65±4.68)cm/s;舒张晚期血流速度(A)(73.29±9.37)cm/s高于对照组(67.54±8.65)cm/s,E峰减速时间(DT)(139.05±14.56)ms长于对照组(132.62±12.74)ms(P<0.05),两组的二尖瓣环舒张早期峰值流速(Em)对比差异无统计学意义(P>0.05);6 min步行距离(6MWT)试验(390.46±20.53)m长于对照组(352.95±16.08)m(P<0.05)。结论食管导联心电图优化LAVI可通过改善双腔起搏器植入的Ⅲ°AVB患者的心脏血流动力学,提高心功能及运动耐力,但对于左室早期的舒张功能影响较小。
出处 《中国疗养医学》 2022年第1期101-103,共3页 Chinese Journal of Convalescent Medicine
  • 相关文献

参考文献10

二级参考文献72

  • 1许原.新型食管心脏电生理刺激仪主要技术进展及应用注意事项[J].心电图杂志(电子版),2013,2(3):168-172. 被引量:2
  • 2张建军,杨明,杨新春,汪爱虎,陈明.起搏导线进入奇静脉的临床表现及处理[J].中华心律失常学杂志,2005,9(1):65-65. 被引量:8
  • 3王方正,张澍,华伟,胡大一,陈新.全国心脏起搏器临床应用调查(2002至2005年)[J].中华心律失常学杂志,2006,10(6):475-478. 被引量:21
  • 4Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities:a report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines. ( Writ- ing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 : e1-62.
  • 5Dickstein K,Vardas PE,Aurlcchio A, et al. 2010 focused update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribu- tion of the Heart Failure Association and the European Heart Rhythm Association. Eur J Heart Fail,2010,12 : 1143-1153.
  • 6McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute mad chronic heart failure 2012. Eur J Heart Fail,2012,14 : 803- 869.
  • 7Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert con- sensus on the monitoring of Cardiovascular Implantable Electronic Devices (CIEDs) : Description of techniques, indications, person- nel, frequency and ethical considerations. Europace, 2008, 10: 707-725.
  • 8Haycs DL, Naccarelli GV, Fuman S, et al. North American Society to Pacing and Electrophysiology. NASPE training requirements for cardiae implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Eleetrophysiol,2003,26 : 1556-1562.
  • 9Naccarelli GV,Conti JB, DiMarco JP,et al. 2008 COCATS 3 Tack Force 6: training in specialized electrophysiology,cardiac pacing, and arrhythmia management. Heart Rhythm ,2008,5:332-337.
  • 10Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol, 2005,28 : 235 -240.

共引文献242

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部